Rothschild Asset Management Inc. lifted its holdings in Amedisys Inc (NASDAQ:AMED) by 6.3% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 468,727 shares of the health services provider’s stock after buying an additional 27,816 shares during the period. Rothschild Asset Management Inc. owned approximately 1.38% of Amedisys worth $26,230,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Ameriprise Financial Inc. boosted its stake in shares of Amedisys by 3.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 177,536 shares of the health services provider’s stock worth $9,934,000 after buying an additional 6,044 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Amedisys by 10.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 846,575 shares of the health services provider’s stock worth $47,375,000 after buying an additional 82,247 shares during the last quarter. Rhumbline Advisers lifted its stake in Amedisys by 3.3% in the third quarter. Rhumbline Advisers now owns 55,951 shares of the health services provider’s stock valued at $3,131,000 after purchasing an additional 1,765 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. lifted its stake in Amedisys by 101.1% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 43,469 shares of the health services provider’s stock valued at $2,433,000 after purchasing an additional 21,850 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan lifted its stake in Amedisys by 62.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 10,710 shares of the health services provider’s stock valued at $599,000 after purchasing an additional 4,120 shares during the last quarter. Hedge funds and other institutional investors own 94.32% of the company’s stock.
AMED has been the topic of a number of analyst reports. BidaskClub raised shares of Amedisys from a “sell” rating to a “hold” rating in a report on Friday, August 11th. Robert W. Baird reissued a “hold” rating and set a $50.00 target price on shares of Amedisys in a report on Wednesday, October 4th. Mizuho reissued a “buy” rating and set a $65.00 target price (up previously from $55.00) on shares of Amedisys in a report on Wednesday, November 8th. Benchmark reissued a “hold” rating on shares of Amedisys in a report on Thursday, November 9th. Finally, Bank of America initiated coverage on shares of Amedisys in a report on Monday, August 21st. They set a “neutral” rating and a $55.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Amedisys presently has an average rating of “Buy” and an average price target of $61.00.
Amedisys Inc (NASDAQ AMED) traded up $1.57 during midday trading on Thursday, reaching $54.53. 414,256 shares of the company’s stock traded hands, compared to its average volume of 331,957. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16. The stock has a market capitalization of $1,786.77, a price-to-earnings ratio of 25.19, a price-to-earnings-growth ratio of 1.27 and a beta of 0.70. Amedisys Inc has a twelve month low of $39.95 and a twelve month high of $65.91.
Amedisys (NASDAQ:AMED) last posted its earnings results on Tuesday, November 7th. The health services provider reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.54 by $0.02. The company had revenue of $380.20 million during the quarter, compared to analyst estimates of $384.59 million. Amedisys had a net margin of 2.88% and a return on equity of 14.68%. Amedisys’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.36 earnings per share. equities analysts expect that Amedisys Inc will post 2.23 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “Rothschild Asset Management Inc. Has $26.23 Million Position in Amedisys Inc (AMED)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/07/rothschild-asset-management-inc-raises-position-in-amedisys-inc-amed.html.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Receive News & Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related companies with MarketBeat.com's FREE daily email newsletter.